Stada’s €5bn LBO to heat up post-summer pipeline
The European leveraged finance markets are licking their lips in anticipation of a new €2.5bn deal backing Bain and Cinven’s takeover of Stada Arzneimittel, the German generic drug manufacturer.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: